AGIO
Agios Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +18.2% ·
aandelenstroom +7.2% ·
netto nieuwe posities +15.4%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | +3 | 38.62M | $1.43B | +11 | −8 |
| Q1 2026 | 89 | 0 | 33.63M | $1.14B | +5 | −5 |
| Q4 2025 | 89 | -2 | 38.17M | $1.04B | — | −2 |
| Q3 2025 | 19 | +2 | 22.49M | $902.53M | +2 | −1 |
| Q2 2025 | 15 | 0 | 21.02M | $699.20M | — | — |
| Q1 2025 | 12 | -1 | 9.99M | $292.81M | — | −1 |
| Q4 2024 | 13 | +2 | 10.10M | $332.03M | +2 | — |
| Q3 2024 | 10 | 0 | 7.27M | $323.20M | — | — |
| Q2 2024 | 10 | — | 7.12M | $306.93M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 2.42M | -14.4% | $79.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.42M | -14.4% | $79.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passief) | 2.15M | — | $70.72M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 1.43M | +12116.0% | $47.11M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.43M | +12116.0% | $47.11M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 1.35M | -0.6% | $44.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 1.35M | -0.6% | $44.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Fisher Asset Management ✦ | 960.66K | +12.3% | $31.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Marshall Wace ✦ | 631.63K | -50.0% | $20.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Marshall Wace ✦ | 631.63K | -50.0% | $20.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 631.63K | -50.0% | $20.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 516.48K | -3.0% | $16.97M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 516.48K | -3.0% | $16.97M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 303.00K | Nieuw | $9.96M | 0.0% | New | 1 | SEC ↗ |
| 15 | Norges Bank ✦ (passief) | 145.09K | -17.5% | $4.77M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 109.37K | Nieuw | $3.59M | 0.0% | New | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 30.86K | -77.7% | $1.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 30.86K | -77.7% | $1.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 30.86K | -77.7% | $1.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 25.49K | -13.4% | $837,568 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 25.49K | -13.4% | $837,568 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 25.49K | -13.4% | $837,568 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Wellington Management ✦ | 25.49K | -13.4% | $837,568 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Millennium Management ✦ | 22.20K | -71.5% | $729,361 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Adage Capital Partners | $9.96M | 0.0% |
| Two Sigma Investments | $3.59M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 231 houders, 62.89M aandelen, $1.99B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.